A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503)
Titel:
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503)
Auteur:
Jonas, Brian A. Fisch, Samantha C. Curtin, Peter T. Schiller, Gary J. Jeyakumar, Deepa Tzachanis, Dimitrios Bejar, Rafael Qi, Lihong Wieduwilt, Matthew J. Tuscano, Joseph M. Damon, Lloyd Logan, Aaron C.